主 办:北 京 中 医 药 大 学
ISSN 1006-2157 CN 11-3574/R

北京中医药大学学报 ›› 2015, Vol. 38 ›› Issue (4): 253-259.doi: 10.3969/j.issn.1006-2157.2015.04.008

• 中药制剂 • 上一篇    下一篇

止痛微乳凝胶膏的制备及体外评价*

章烨雯,王琼,于竞新,李辉,康倩,张庆,谭鹏,吴清#   

  1. 北京中医药大学中药学院 北京 100102
  • 收稿日期:2014-10-15 出版日期:2015-04-15 发布日期:2015-04-15
  • 通讯作者: 吴清,女,教授,博士生导师,研究方向:中药新剂型与新技术研究, E-mail:qwu@vip.sina.com.
  • 作者简介:章烨雯,女,在读硕士生
  • 基金资助:
    *国家自然科学基金资助项目(No. 81473365), 北京市自然科学基金资助项目(No.7132127), 北京中医药大学创新团队发展计划项目(No.2011-CXTD-13)

Preparation and in vitro evaluation of analgesic microemulsion cataplasm*

ZHANG Ye-wen, WANG Qiong, YU Jing-xin, LI Hui, KANG Qian, ZHANG Qing, TAN Peng, WU Qing#   

  1. School of Chinese Materia Medica,Beijing University of Chinese Medicine,Beijing 100102
  • Received:2014-10-15 Online:2015-04-15 Published:2015-04-15

摘要: 目的 探讨微乳技术对凝胶膏中药物释放及透皮性能的影响。方法 以初黏力、180°剥离强度和综合感官评分为指标,结合单因素实验与星点设计-效应面法优选止痛微乳凝胶膏处方。采用改良Franz扩散池法,以有效成分阿魏酸和欧前胡素为指标,对比微乳凝胶膏和普通凝胶膏体外释放和经皮渗透性能。结果 最终优选出基质配方为NP700,卡波姆-941,卡波姆-934,铝化合物,酒石酸,丙三醇(1∶0.1∶0.25∶0.04∶0.04∶6)。2种凝胶膏中有效成分的体外释放均符合零级动力学方程,具有扩散和溶蚀的双重机制。微乳凝胶膏和普通凝胶膏中阿魏酸的透皮速率分别为1.92、0.97 μg/(h·cm2),欧前胡素的透皮速率分别为0.28、0.09 μg/(h·cm2)。与普通凝胶膏相比,微乳凝胶膏中有效成分的累积透过率成倍数增加。结论 微乳技术能促进凝胶膏中药物的经皮渗透。

关键词: 微乳, 凝胶膏, 星点设计-效应面法, 阿魏酸, 欧前胡素, 体外释放, 透皮率

Abstract: Objective To investigate the influence of microemulsion technology on release capability and transdermal permeability of components in cataplasm. Methods With the initial bonding strength, 180 degree force strength and sensory evaluation scores as indicators, the formula of the analgesic microemulsion cataplasm matrix was optimized by using single factor experiment combined with central composite design-response surface design methodology. Modified Franz diffusion cell was used to compare the release capability and transdermal permeability between analgesic microemulsion cataplasm (MEC) and analgesic common cataplasm (CC) with indicators of ferulic acid and imperatorin. Results Optimized matrix formula was NP700, carbomer 941, carbomer 934, aluminum compounds, tartaric acid and glycerin with the ratio of 1∶0.1∶0.25∶0.04∶0.04∶6 . The release capability in vitro of ferulic acid and imperatorin in MEC and CC conformed to zero-order kinetic equation with a dual mechanism of diffusion and dissolution. The steady-state permeation rate of ferulic acid in MEC was 1.92 μg/(h·cm2) and that in CC was 0.97 μg/(h·cm2); that of imperatorin in MEC was 0.28 μg/(h·cm2), while in CC was 0.09 μg/(h·cm2). Compared with CC, the cumulative release rate of effective components multiplied. Conclusion Microemulsion technology can significantly promote the transdermal permeability of components in cataplasm.

Key words: microemulsion, cataplasm, central composite design-response surface design methodology, ferulic acid, imperatorin, release capability in vitro, transdermal permeability

中图分类号: 

  • R283.62+1